Safety, Protective Immunity, and DIVA Capability of a Rough Mutant Salmonella Pullorum Vaccine Candidate in Broilers by Rongxian Guo et al.
fmicb-08-00547 April 3, 2017 Time: 15:40 # 1
ORIGINAL RESEARCH
published: 05 April 2017
doi: 10.3389/fmicb.2017.00547
Edited by:
Kuldeep Dhama,
Indian Veterinary Research Institute,
India
Reviewed by:
Maryam Dadar,
Razi Vaccine and Serum Research
Institute, Iran
Muhammad Zubair Shabbir,
University of Veterinary and Animal
Sciences, Pakistan
Jonathan Lalsiamthara,
Chonbuk National University,
South Korea
*Correspondence:
Xinan Jiao
jiao@yzu.edu.cn
Specialty section:
This article was submitted to
Microbial Immunology,
a section of the journal
Frontiers in Microbiology
Received: 13 January 2017
Accepted: 16 March 2017
Published: 05 April 2017
Citation:
Guo R, Jiao Y, Li Z, Zhu S, Fei X,
Geng S, Pan Z, Chen X, Li Q and
Jiao X (2017) Safety, Protective
Immunity, and DIVA Capability of a
Rough Mutant Salmonella Pullorum
Vaccine Candidate in Broilers.
Front. Microbiol. 8:547.
doi: 10.3389/fmicb.2017.00547
Safety, Protective Immunity, and
DIVA Capability of a Rough Mutant
Salmonella Pullorum Vaccine
Candidate in Broilers
Rongxian Guo, Yang Jiao, Zhuoyang Li, Shanshan Zhu, Xiao Fei, Shizhong Geng,
Zhiming Pan, Xiang Chen, Qiuchun Li and Xinan Jiao*
Jiangsu Key Laboratory of Zoonosis, Jiangsu Co-Innovation Center for Prevention and Control of Important Animal
Infectious Diseases and Zoonoses, Yangzhou University, Yangzhou, China
Salmonella enterica subsp. enterica serovar Gallinarum biovar Pullorum (Salmonella
Pullorum) is highly adapted to chickens causing an acute systemic disease that results
in high mortality. Vaccination represents one approach for promoting animal health,
food safety and reducing environmental persistence in Salmonella control. An important
consideration is that Salmonella vaccination in poultry should not interfere with the
salmonellosis monitoring program. This is the basis of the DIVA (Differentiation of
Infected and Vaccinated Animals) program. In order to achieve this goal, waaL mutant
was developed on a spiC mutant that was developed previously. The safety, efficacy,
and DIVA features of this vaccine candidate (Salmonella Pullorum 1spiC1waaL) were
evaluated in broilers. Our results show that the truncated LPS in the vaccine strain
has a differentiating use as both a bacteriological marker (rough phenotype) and also
as a serological marker facilitating the differentiation between infected and vaccinated
chickens. The rough mutant showed adequate safety being avirulent in the host
chicks and showed increased sensitivity to environmental stresses. Single intramuscular
immunization of day-old broiler chicks with the mutant confers ideal protection against
lethal wild type challenge by significantly stimulating both humoral and cellular immune
responses as well as reducing the colonization of the challenge strain. Significantly
lower mean pathology scores were observed in the vaccination group compared to
the control group. Additionally, the mutant strain generated cross-protection against
challenge with the wild type Salmonella Gallinarum thereby improving survival and with
the wild type Salmonella Enteritidis thereby reducing colonization. These results suggest
that the double-mutant strain may be a safe, effective, and cross-protective vaccine
against Salmonella infection in chicks while conforming to the requirements of the DIVA
program.
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INTRODUCTION
In poultry, the infectious bacteria Salmonella enterica subsp. enterica can be divided in two broad
groups of serovars on the basis of pathogenesis and infection biology (EFSA, 2004). One group,
containing the serovar Gallinarum biovars Pullorum and Gallinarum, causes a severe systemic
typhoid-like disease in a restricted range of hosts (Barrow and Freitas Neto, 2011). The other group,
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containing the serovar Enteritidis, causes gastrointestinal disease
in a wide range of hosts including humans. Salmonella Pullorum
is highly adapted to young chicks under 3 weeks of age, and
results in acute systemic disease and high mortality. In many
developing countries, Salmonella Pullorum infections in poultry
are common and pullorum disease remains the principal disease
threat to the fowl industry (Guo et al., 2016). Salmonella
Enteritidis is the cause of the food-borne salmonellosis pandemic
in humans, in part because it has the unique ability to
contaminate poultry products without causing discernible illness
in the birds infected (Guard-Petter, 2001). Therefore, there is a
need for methods that protect broilers, from day-of-hatch until
slaughter age, against infection with Salmonella Pullorum, as
well as to reduce the contamination of the food-borne serotype
Salmonella Enteritidis.
Vaccination of chicks has offered a promising future and
there continues to be progress in the development of a
safe and efficacious Salmonella vaccine that provides broad
cross-protection for enhancing both animal health and food
safety (Heithoff et al., 2015). Salmonella Pullorum is likely
to be eliminated from poultry solely by relying on the test-
and-slaughter method of disease control (World Organization
for Animal Health [OIE], 2008). Pullorosis sero-diagnosis
is generally based on the detection of antibodies against
Salmonella lipopolysaccharides (LPS) by use of a macroscopic
tube agglutination test, a rapid serum plate agglutination (SPA)
test, a stained antigen whole blood test, or a micro-agglutination
test (Shivaprasad, 2000). Due to the fact that breeding flocks
are screened for specific serum antibodies against Salmonella
LPS using the SPA test (Gast, 1997), antibodies produced
following vaccination are indistinguishable from those produced
in response to a wild type Salmonella Pullorum infection.
A central goal in ideal vaccine development is that it should
not interfere with this salmonellosis monitoring program. The
concept of DIVA vaccines based on the absence of at least one
immunogenic protein or antigen in the vaccine, but which is
present in the wild type strain, has already been proposed for
commercial veterinary use (Selke et al., 2007; Leyman et al.,
2011; Román et al., 2012). Moreover, the ability of live vaccine
to shed and to persist in the environment should be tested to
provide information for assessing the unacceptable hazard of the
prolonged survival to the environment (Leyman et al., 2012).
The need to remove wild type genes in order to distinguish
vaccinated strains from wild type strains offer new opportunities.
In this regard, the construction of novel attenuated Salmonella
vaccine strains has focused both on the deletion of virulence
factors as well as the disruption of metabolic pathways, while at
the same time balancing safety and immunogenicity (Galen and
Curtiss, 2014). LPS is a major virulence factor and the O-antigen
is the immunodominant antigen in serological diagnosis tests.
Truncating the O-antigen and preventing its synthesis are two
strategies for attenuating Salmonella for use as a DIVA vaccine
(Kong et al., 2011). WaaL is a membrane enzyme implicated
in ligating the O-antigen to the lipid A-core oligosaccharide.
The presence or absence of the O-chain antigen determines
whether the LPS is smooth or rough respectively. Mutations
in the waaL gene result in bacteria possessing a rough LPS
(Pérez et al., 2008). However, the waaL deletion mutant (such
as Salmonella Typhimurium 1waaL) has been found to be
insufficiently attenuated (Nagy et al., 2008) and so a second
virulence gene was thought to be required. SpiC is required
for translocation of SPI-2 (Salmonella pathogenicity island 2)
effectors (Geng et al., 2014) and so spiC, was selected as an
additional attenuating deletion.
The objectives of the present study were to evaluate the safety
and protective capacity of a Salmonella Pullorum 1spiC1waaL
double-mutant strain following intramuscular inoculation of
day-old broilers and to evaluate the usefulness of this strain as
DIVA strategy.
MATERIALS AND METHODS
Chickens
HY-line white chicken embryos, obtained from Jiangsu Institute
of Poultry Sciences (China), were hatched in the laboratory. The
chickens were checked to confirm the absence of Salmonella
infection by bacteriological examination as described below and
for any clinical signs of enteric disease. Experimental groups
were housed in separate wire cages with sufficient formulated
feed and water at ambient temperature. All experimental and
animal management procedures were permitted by the Animal
Welfare and Ethics Committees of Yangzhou University (SYXK
[Su] 2012–0029), and complied with the guidelines of the
institutional administrative committee and ethics committee of
laboratory animals. All laboratory health and safety procedures
were complied with during the course of the experimental work.
Bacterial Strains and Development of
Salmonella Pullorum Mutant Strain
The Salmonella Pullorum S06004 strain, originally isolated from
chicks with pullorum disease, is naturally resistant to nalidixic
acid (Nal) (Geng et al., 2014), and was used as the challenge strain.
A spiC deletion mutant strain, S060041spiC (Guo et al., 2016),
was used as the background strain for the construction of the
LPS rough mutant. Deletion of the waaL gene was performed
using the one-step inactivation method as described previously
(Datsenko and Wanner, 2000). The targeted gene was deleted
from start to stop codon, as confirmed by sequencing. The
Salmonella Pullorum S060041spiC1waaL mutant strain was
used for immunization of chicks. The Salmonella Gallinarum
virulent strain SG9 NalR, supplied by Barrow (1990), and
Salmonella Enteritidis F06 NalR, isolated from dead poultry farm
chickens, were used as challenge strains.
LPS Extraction, Silver Staining and
Immunoblot Analysis
Lipopolysaccharides was extracted by phenolic based extraction
method using LPS extraction kit (iNtRON, Korea), the procedure
involved lysis, precipitation, purification and resuspension. LPS
samples were separated on 12% SDS-PAGE gels (sodium dodecyl
sulfate polyacrylamide gel electrophoresis) and stained using a
silver stain kit (Thermo Scientific, USA). Western blotting was
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performed using an anti-O9 monoclonal antibody and goat anti-
mouse IgG HRP (1:5000; Sigma–Aldrich, USA). An acriflavine
slide test was carried out to detect the rough colony phenotype
characteristic of the mutant strain (Cerdà-Cuéllar and Aragon,
2008). Briefly, Colonies of a 24-h culture prepared from the
vaccine strain on nutrient agar plates were mixed with 30
microlitres of 0.2% acriflavine on a glass slide. Mixtures were
rotated for 1 min and observed for macroscopic evidence of
agglutination.
Assessment of LD50 and Organ
Colonization
For determination of the 50% lethal dose (LD50), groups of
10-day-old chicks were infected intramuscularly with 10-fold
dilutions (from 105 to 1010 CFU) of S060041spiC1waaL or
S06004. Birds were observed for 3 weeks post-infection, and
deaths were recorded daily to calculate the LD50 values.
Bacterial persistence and clearance were analyzed to
determine the number of live vaccine strain by counting Nal
resistant Salmonella per gram of liver or spleen. Forty chicks
obtained on the day of hatching, were randomly divided into two
equal groups. The vaccinated group was injected intramuscularly
with 1 × 107 CFU live vaccine, whereas the control group
received 100 µl PBS. Following on from this, 2, 7, 14, and 21 days
post vaccination, the liver and spleen were obtained from each
group of five birds using aseptic technique, weighed, and then
homogenized. Dilutions of the homogenate were incubated on
selective XLT4 (Difco, USA) agar containing 100 µg/ml Nal at
37◦C and the resulting Salmonella colonies were counted.
Vaccination Experiments
Immunization and Protection against Salmonella
Pullorum Challenge
Forty day-old chicks were divided into two groups
(n = 20/group), designated as group A (non-vaccinated
control) and group B (vaccinated), to evaluate the protective
efficacy of the Salmonella Pullorum mutant following a single-
dose intramuscular injection. These two groups of day-old
chicks were injected with 100 µl of PBS (pH 7.2) or PBS
containing ∼1 × 107 CFU of the S060041spiC1waaL mutant
strain. Animals were challenged intramuscularly with 109 CFU
of virulent Salmonella Pullorum 14 days post-immunization
(dpi) (Guo et al., 2016). Deaths and clinical symptoms were
recorded daily for a further 2 weeks. At the end of this period, all
surviving chicks were sacrificed. Clinical scores were determined
and recorded using a system as we have previously described
Guo et al. (2016). Organs (liver, spleen, and cecum) were
collected from each group of five birds aseptically, weighed, and
homogenized to check for the presence of the challenge strain.
Dilutions of the homogenate were made in sterile PBS (pH 7.2)
and plated onto selective XLT4 (Difco, USA) agar containing
100 µg/ml Nal.
Cross-Protection against Homologous Serotype
Four groups of 20 day-old chicks were vaccinated with
S060041spiC1waaL as described in Section “Immunization and
Protection against Salmonella Pullorum Challenge.” At 50 days
of age, the chicks were injected intramuscularly with 109 CFU of
the virulent Salmonella Gallinarum strain SG9 or with 109 CFU
Salmonella Enteritidis F06. Mortality was recorded over a period
of 2 weeks.
Protection against Salmonella Enteritidis induced by the
vaccine strain was assessed by analyzing the ability of the
challenge strain to colonize the gastrointestinal tract, liver,
and spleen of vaccinated and control chickens. Fourteen days
after challenge, five birds from each group were sacrificed and
tissue homogenates were prepared. Appropriate dilutions of
the homogenates were plated on XLT4 agar plates containing
100 µg/ml Nal for the enumeration of Salmonella Enteritidis
present in each tissue.
Production of Antibodies and
Lymphocyte Stimulation Assay
An indirect-ELISA method using heat-killed whole Salmonella
Pullorum bacteria as coating antigen was applied to quantify IgG
in the serum, as described previously (Guo et al., 2016). Briefly,
bacterial antigen was coated in 96-well plate and incubated
overnight at 4◦C. After blocking, the sera samples collected on
days 7, 14, 21, and 28 were diluted and added to the wells. Wells
were incubated with a 1:5000 dilution of horseradish peroxidase-
conjugated goat anti-chicken IgG secondary antibody (Sigma–
Aldrich, USA) for 1 h. Absorbance at 405 nm was measured
with an automated microplate reader (Synergy 2, BioTek, USA)
after the reaction was stopped with 2 M H2SO4. The optical
density (OD) values obtained were used to calculate the adjusted
E-values using the following formula: E-value = [OD (sample) –
OD (negative control)/OD (positive control) – OD (negative
control)]. To evaluate the impact of the vaccine candidate on
the cell-mediated immune (CMI) response post-immunization, a
peripheral lymphocyte proliferation assay was carried out on day
21 as described previously (Rana and Kulshreshtha, 2006).
Capability of DIVA Based Serodiagnosis
The SPA test was used to assess the DIVA capability of
the S060041spiC1waaL vaccine candidate (Gast, 1997;
Lalsiamthara et al., 2015). The commercially available plate test
Salmonella Pullorum antigens were obtained from Zhonghai
Biotech (Beijing, China). Day-old chicks were immunized
intramuscularly with the vaccine strain or the S060041spiC
mutant (smooth LPS phenotype). Serum were prepared on days
7, 14, 21, and 28 by collecting blood via heart puncture and
allowing it to coagulate for 3 h at room temperature before
collection of the serum fraction. Serum samples from vaccinated
birds (30 µl) were mixed with an equal volume of standard SPA
test antigen and the agglutination reaction was observed.
Environmental Safety Evaluation
The sensitivity of the S060041spiC1waaL mutant to ultraviolet
light and various disinfection agents was evaluated as described
(Leyman et al., 2012; Han et al., 2014), with minor modifications.
Bacteria were grown to OD600 = 1.0 at 37◦C with shaking and
were diluted in PBS to 109 CFU/ml. One milliliter of suspension
was then transferred to a sterile petri dish and exposed to
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FIGURE 1 | Phenotypic characterization of LPS in mutant and wild type strains. (A) SDS-PAGE of LPS analyzed by silver staining. (B) Western blotting
analysis of LPS using an anti-O9 monoclonal antibody. (C) Mutant strain has a rough appearance using the acriflavine agglutination test. (D) Schematic
representation of the Salmonella Pullorum LPS molecule (lipid A, core polysaccharides and O-antigen).
ultraviolet radiation (PHILIPS, UV-C: 254 nm, 30 W, distance:
45 cm) for 1 min. For oxidative and alkali tolerance, each
suspension was incubated in the presence of stressors at room
temperature: 100 µM hydrogen peroxide for 5 min or 12.5 mM
sodium hydroxide (NaOH) for 5 min. The susceptibility of strains
to compound peroxymonosulphate powder, which is the active
ingredient in a selected disinfectant (DuPontTM Virkon R© S,
Shenzhen, China) was analyzed by a microdilution assay using
serial, two-fold dilutions. Finally, 10-fold dilutions were plated
onto LB plates to quantify viable bacteria. The experiment was
performed three times.
Statistical Analysis
Statistical analysis was performed using GraphPad Prism 5
(GraphPad Software, USA). One-way ANOVA followed by a
Dunnett’s multiple comparison tests was used to determine
the statistical differences between multiple experimental groups.
P < 0.05 was considered statistically significant.
RESULTS
The waaL Mutant Shows Truncated LPS
Lacking the O-Antigen Region
To confirm that O-antigen biosynthesis was affected, the LPS
profiles of wild type and mutant strains were compared using
silver staining of LPS preparations. As shown in Figure 1A, the
LPS from the wild type strain displayed a ladder-like pattern with
varying lengths of O-polysaccharide repeats, whereas the mutant
with the waaL gene had a rough type A (Ra) LPS structure.
Furthermore, western blotting confirmed the lack of reactivity
of the waaL mutant LPS with an anti-O9 monoclonal antibody
indicating that the LPS lacked the O-antigen (Figure 1B).
The wild type strain and the waaL mutant strain could be
distinguished from each other using the acriflavine slide test.
The mutant strain displayed a rough-phenotype whereas the wild
type strain displayed smooth-phenotype since it did not cause
agglutination (Figure 1C).
Determination of the Attenuation of
1spiC1waaL Strain
In order to confirm the safety of the mutant strain as a live
vaccine candidate, the virulence of parent and mutant strains
were evaluated in day-old HY-line white chicks. The LD50 of
the S060041spiC1waaL was approximately 400-fold higher than
that of the parent strain for intramuscular infection (Table 1).
Organ Colonization and Persistence
The results of bacteria persistence and clearance in organs
are shown in Figure 2. Bacteriological analysis showed that
inoculation with the mutant strain resulted in a high level
of internal organ colonization 2 days post-vaccination and
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TABLE 1 | Characteristics of Salmonella Pullorum mutants.
Strain Morphology LD50 (CFU) a
S06004 Smooth 1.0 × 107
S060041spiC Smooth 1.20 × 109
S060041spiC1waaL Rough 3.98 × 109
aChicks were infected intramuscularly with the mutant strains.
FIGURE 2 | Colonization and persistence of the vaccine strain in liver
and spleen after inoculation of day-old chicks with 107 CFU bacterial
cells. Values are represented as log10 CFU/g sample. Negative samples are
shown as 0 CFU/g; all samples from the control group were negative.
persistence for about 2 weeks, suggesting the vaccine strain
maintained the ability to invade the host and to stimulate an
immune response. In general, however, the persistence of the
strain declined gradually over the course of the experiment. All
samples taken 21 days after inoculation were negative, indicating
that the mutant strain was efficiently cleared.
Protective Efficacy against Virulent
Salmonella Pullorum Challenge
Chicks that were inoculated with the vaccine showed significantly
higher protection against Salmonella Pullorum challenge
compared to non-immunized chicks. No mortality was observed
in the immunized group whereas 16 out of 20 broilers died in
the non-vaccinated group (Figure 3A). Post-challenge, the mean
pathology scores of the vaccinated group and the control group
were 1.10 ± 1.77 and 4.70 ± 0.66, respectively, indicating that
immunized chicks received significantly lower mean scores than
controls. The vaccinated birds also had a significant reduction in
challenge bacterial counts in the organs (Table 2).
Cross-Protection against Virulent
Salmonella Gallinarum or Salmonella
Enteritidis Challenge
To evaluate the cross-protective effect of the live vaccine,
vaccinated chicks were challenged with the virulent Salmonella
Gallinarum strain SG9 or the Salmonella Enteritidis strain F06.
Following challenge with virulent SG9, none of the chicks died
in the vaccinated group, whereas only two chicks survived in
the non-vaccinated group (Figure 3B). Bacteriological analysis of
the tissues from vaccinated birds following virulent Salmonella
Enteritidis challenge showed that the wild type strain could not
be detected in either systemic organs or the cecum; this was not
the case in the control group (Table 2).
Humoral and Cellular Immune Response
Generated by the Vaccine Candidate
Statistical analysis showed a significant difference in both the
humoral and cellular immune response in chickens immunized
with the vaccine compared with the control animals. Serum
IgG levels were significantly higher at every time point post-
immunization in the treatment group (Figure 4). In vaccinated
chicks, the level of the lymphocyte proliferative response,
indicated by the stimulation index (SI), was significantly higher
compared to control chicks (Figure 4).
Differentiation of Serum Antibodies to
Salmonella Pullorum
Antibodies to Salmonella Pullorum are often detected by the
SPA test using the standard antigen. Serum collected from
S060041spiC1waaL vaccinated chicks at different time intervals
was identified as SPA negative post-inoculation (Figure 5).
However, chicks were identified as positive in the group
vaccinated with the spiC strain. Overall, the live vaccine has
shown obvious DIVA capability which could be extremely useful
in the salmonellosis control program.
The Mutant Strain Shows Enhanced
Sensitivity to Environmental Stress
High UV sensitivity was demonstrated in both wild type and
attenuated vaccine strains with no cells from either surviving
after UV-C irradiation. In terms of oxidative stress, the percent
survival of the mutant strain fell by approximately 84.5% and
they demonstrated a markedly higher sensitivity to hydrogen
peroxide than wild type cells (48.8%) (Figure 6). The LPS
deficient strain was highly susceptible to alkaline treatment
compared to the corresponding wild type strain (Figure 6). The
minimum bactericidal concentration analysis showed that the
rough mutant was much more sensitive to the killing effects
of compound peroxymonosulphate powder than the wild type
strain, with a significant reduction in number of surviving
cells at some range of concentrations (Table 3). Consequently,
the live vaccine candidate was unable to persist under adverse
conditions, suggesting that it could be easily eliminated from the
environment.
DISCUSSION
Salmonella Pullorum causes outbreaks in poultry, resulting
in high chick morbidity and mortality (Xiong et al., 2016).
Vaccination is not a panacea but should always be used as a part
of a comprehensive control program. Live attenuated vaccines
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FIGURE 3 | Protective ability of the rough mutant against the virulent Salmonella enterica serovar Gallinarum biovar Pullorum and Gallinarum
challenge. At fourteen dpi, chicks from each group were challenged intramuscularly with 1 × 109 CFU wild-type Salmonella Pullorum S06004 (A) or virulent
Salmonella Gallinarum SG9 (B). Protection was expressed by percentage survival after challenge (∗∗∗P < 0.001).
TABLE 2 | Recovery of Salmonella from various chick organs vaccinated with the mutant strain or non-immunized control chicks subsequently
challenged with virulent Salmonella.
Treatment Salmonella Pullorum (lgCFU/g) Salmonella Enteritidis (lgCFU/g)
Liver Spleen Cecum Liver Spleen Cecum
Vaccination 0.92 ± 0.15a 2.11 ± 0.53a 4.04 ± 0.23a –a,b –a,b –a,b
Control 3.40 ± 0.49 4.09 ± 0.14 5.57 ± 0.41 1.16 ± 0.36 3.0 ± 0.34 4.23 ± 0.65
aP < 0.01 compared to PBS controls. bNo Salmonella Enteritidis challenge strain detected.
FIGURE 4 | Levels of humoral and cellular immune responses in vaccinated versus control chicks. Serum IgG antibody responses against the live vaccine
strain measured by indirect-ELISA. Asterisks indicate a significant difference between the immunized and PBS control groups (∗P < 0.05; ∗∗P < 0.01). Stimulation
index of lymphocyte stimulation responses using soluble antigens in immunized chickens at 3 weeks post vaccination. Asterisks indicate a significant difference
compared with the PBS control group (∗P < 0.05).
have been tested extensively in poultry and also in mice, although
only a few Salmonella strains are registered and commercially
available for use in poultry (Barrow, 2007). Ideally, a vaccine used
to control Salmonella infection should be safe, cross-protective,
well defined, and capable of inducing cellular immunity (Desin
et al., 2013).
Genetic modification of the Salmonella vaccine strain aims
at reducing the risk of persistence or spread in host tissues
and in the environment while at the same time inducing an
efficient immune response. Double mutations introduced into
bacteria can develop a highly attenuated and safety-enhanced
vaccine strain and thereby reduce the risk of reversion by
acquisition of genes through horizontal transfer (Van Immerseel
et al., 2005). The O-antigen provides important elements in
serological distinction and plays a direct role in virulence such
as invasion, colonization, and resistance. The WaaL protein is
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FIGURE 5 | Capability of DIVA based on a serum plate agglutination test. Serum collected on days 7, 14, 21, and 28 were tested for reactivity to the
Salmonella Pullorum standard antigen. Chicks in the S060041spiC control group showed a strong agglutination reaction (+/++) on days 21 and 28 post inoculation.
FIGURE 6 | Mutant strain survival rates under different environmental stress. The susceptibility of the Salmonella Pullorum mutant strain and its parental
strain to hydrogen peroxide (100 µM for 5 min) and 12.5 mM NaOH for 5 min. Data are the means and standard deviations of three experiments (∗∗∗P < 0.001).
known to be involved in the ligation of O-antigen to lipid
A-core oligosaccharide (Kaniuk et al., 2004). The waaL mutant
in our vaccine strain produces rough LPS lacking the O-antigen
repeat units (Figure 1). SPI-2 T3SS (type III secretion system) is
involved in the avoidance of or resistance to macrophage killing
mechanisms, SpiC is part of a three-protein regulatory complex
that functions within Salmonella to mediate the switch from
TABLE 3 | Susceptibility of Salmonella Pullorum mutant strain to
peroxymonosulphate powder.
Strain Cell counts
1:200 1:400 1:800 1:1600
WT 0 182 ± 88.50 –a –a
Mutant 0 0 16 ± 11.79 –a
aNot counted.
translocon protein secretion to effector translocation (Figueira
and Holden, 2012). Because of this central role, single deletion
of the spiC gene results in significant attenuation in Salmonella
Pullorum. Our results demonstrate that the S060041spiC1waaL
double mutant was highly avirulent in day-old chicks because it
was unable to cause mortality even at the high bacterial loads used
for vaccination.
Bacterial susceptibility to different disinfection agents is
an important measure of the fitness of a vaccine strain to
survive in the environment (Leyman et al., 2012). LPS plays
an important role in bacterial defense mechanisms against
antimicrobial substances (Liu et al., 2014). O-antigen is the
characteristic polysaccharide of the outermost component of the
outer membrane of the gram-negative bacteria cell wall. The
presence of O-polysaccharide in LPS molecules may prevent
antimicrobial substances from reaching their binding sites in
the cell wall, resulting in enhanced tolerance and survival. The
mutant strain we have developed is highly susceptible to various
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environmental stresses, indicating that the live vaccine candidate
will be likely be unable to persist under adverse conditions and
will be easily eliminated from the environment. In addition to
this, the vaccine strain was eliminated from the broilers before
slaughter age, therefore showing a good safety profile. These
results indicate that the vaccine candidate is sufficiently safe for
chicks.
Besides safety, the efficacy of the vaccine is also important.
Humoral and cellular immune responses induced by Salmonella
vaccine play an important role in preventing infection (Penha
Filho et al., 2012). Measurement of the levels of Salmonella
specific antibodies is used to monitor humoral immune
responses. Chicks from the immunized group had significantly
higher serum IgG levels compared with chicks in the control
group. The role of CMI in Salmonella resistance has been shown
to involve both the acquired and innate immune responses.
Furthermore, enhanced CMI may prove beneficial in protecting
avian species against these intracellular bacterial infections (Babu
et al., 2003). Measurement of CMI in vaccinated birds was
carried out to investigate the effects of the vaccine on peripheral
lymphocyte proliferation. In this study, the live vaccine was
effective in increasing peripheral lymphocyte proliferation in
response to the Salmonella Pullorum soluble antigen. Overall, the
vaccine strain induced a robust humoral immune response as well
as an effective CMI response.
Salmonella Pullorum, Salmonella Gallinarum and Salmonella
Enteritidis all belong to the Salmonella serogroup D and cross-
protection of the vaccine is therefore to be expected. Bacterial
mutants with a truncated LPS, like the mutant used here, may
have the potential to serve as a vaccine that generates cross-
protective immunity to other serovars (Nagy et al., 2008; Kong
et al., 2011; Leyman et al., 2011). The rough strain of Salmonella
Gallinarum 9R has been used as a vaccine to protect chickens
against fowl typhoid. Besides controlling fowl typhoid, the SG
9R vaccine has been used in several countries as an additional
tool in the control of Salmonella Enteritidis in commercial layer
flocks (Wigley, 2017). Recently, it has been suggested that rough
mutants provide better accessibility of lipid A and core antigens,
while at the same time they facilitate refocusing of the immune
response to outer membrane proteins (Bearson et al., 2016; Liu
et al., 2016). Therefore, a cross-protection study was carried
out to investigate the ability of the rough Salmonella Pullorum
vaccine candidate on cross-immunity. The mutant strain was able
to provide cross-protection following challenges with wild type
Salmonella Gallinarum by reducing mortality and with wild type
Salmonella Enteritidis by preventing colonization. As more than
one serogroups of Salmonella in the poultry community, we will
evaluate the cross-protective immunity and protection efficacy
against heterologous serotype Salmonella, such as Salmonella
Typhimurium and Salmonella Infantis, in future works.
The basis for successful control of Salmonella Pullorum
infections in poultry are good farming and hygienic practices as
well as testing and removal of positive flocks from populations.
When vaccination is used in Salmonella control programs,
possible interferences with the standard Salmonella serological
detection methods are considered to be a major drawback
since the immunized animals produce antibodies against the
vaccine strain that cannot be distinguished by serological tests
from animals infected with wild type strains (Adriaensen et al.,
2007). The success of an LPS based DIVA vaccine (Salmonella
Gallinarum 9R) in the control of fowl typhoid and paratyphoid
has shown that live attenuated, but distinguishable, bacterial
strains provide evidence of a path forward (Silva et al., 1981).
Salmonella Gallinarum 9R is a mutation in the rfaJ gene and
results in a rough LPS phenotype because of a defective O-antigen
side chain (Kwon and Cho, 2011). One of the greatest advantages
of the use of the 9R vaccine is that it gives good protection
and does not interfere with the tests used for pullorum-typhoid
control. In the present study, the waaL gene mutant displayed
a truncated LPS lacking the main surface antigen, similar to
Salmonella Gallinarum 9R. The serologic results obtained from
vaccinated birds were negative, however, the samples tested
positive in wild type infected animals. Our results illustrate that
the S060041spiC1waaL mutant strain was able to stimulate
a DIVA humoral immune response in chickens and show a
satisfactory performance in the serologic tests in the Salmonella
control program.
In summary, we have demonstrated that the rough attenuated
Salmonella Pullorum vaccine candidate had attributes desirable
in a vaccine including, attenuation, immunogenicity, and DIVA
feature. This mutant strain may therefore be an efficacious
vaccine in controlling Salmonella infection in poultry. Further
efforts are necessary to determine the vaccine efficacy in
field trials and to develop efficient control strategy against
salmonellosis.
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